Hiroko Onagi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 01, 2026
Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situ.
Journal: Human pathology
Published: March 25, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.
Journal: Annals of surgical oncology
Published: January 26, 2026
A Case of Breast Cancer with Cystic Axillary Lymph Node Metastasis.
Journal: Surgical case reports
Published: March 24, 2025
Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosis.
Journal: Breast cancer (Tokyo, Japan)
Published: February 04, 2025
Potential Involvement of Myostatin in Smooth Muscle Differentiation in Pleomorphic Leiomyosarcoma.
Journal: International journal of molecular sciences
Published: December 31, 2024
Granulomatous mastitis forming a well-defined large mass diagnosed by surgical excision: a case report.
Journal: Surgical case reports
Published: July 11, 2024
Attempt to Substitute the Oncotype DX Breast Recurrence Score® Test by Histopathological Factors and MUC1 Protein Expression.
Journal: Cancer diagnosis & prognosis
Published: March 05, 2024
HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti-HER-2/neu (4B5).
Journal: Pathology international
Published: November 15, 2023
Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia.
Journal: Heliyon
Published: October 10, 2023
Last Updated: 09/26/2026